Dysregulation of MFN2 can lead to neurodegeneration, sarcopenia, metabolic disease, heart disease and many other diseases (Sebastian et al., 2016; Kim et al., 2017; Chandhok et al., 2018; Rocha et al., 2018). The gene discussed is MFN2; the disease is Other metabolic disease.